Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities

Emons G, Steiner E, Vordermark D, Uleer C, Bock N, Paradies K, Ortmann O, Aretz S, Mallmann P, Kurzeder C, Hagen V, Van Oorschot B, Hoecht S, Feyer P, Egerer G, Friedrich M, Cremer W, Prott FJ, Horn LC, Prompeler H, Langrehr J, Leinung S, Beckmann M, Kimmig R, Letsch A, Reinhardt M, Alt-Epping B, Kiesel L, Menke J, Gebhardt M, Steinke-Lange V, Rahner N, Lichtenegger W, Zeimet A, Hanf V, Weis J, Mueller M, Henscher U, Schmutzler RK, Meindl A, Hilpert F, Panke JE, Strnad V, Niehues C, Dauelsberg T, Niehoff P, Mayr D, Grab D, Kreissl M, Witteler R, Schorsch A, Mustea A, Petru E, Huebner J, Rose AD, Wight E, Tholen R, Bauerschmitz GJ, Fleisch M, Juhasz-Boess I, Lax S, Runnebaum I, Tempfer C, Nothacker MJ, Bloedt S, Follmann M, Langer T, Raatz H, Wesselmann S, Erdogan S (2018)

Publication Type: Journal article

Publication year: 2018

Journal

Book Volume: 78

Pages Range: 1089-1109

Journal Issue: 11

DOI: 10.1055/a-0715-2964

Abstract

Summary The first German interdisciplinary S3-guideline on the diagnosis, therapy and follow-up of patients with endometrial cancer was published in April 2018. Funded by German Cancer Aid as part of an Oncology Guidelines Program, the lead coordinators of the guideline were the German Society of Gynecology and Obstetrics (DGGG) and the Gynecological Oncology Working Group (AGO) of the German Cancer Society (DKG). Purpose Using evidence-based, risk-adapted therapy to treat low-risk women with endometrial cancer avoids unnecessarily radical surgery and non-useful adjuvant radiotherapy and/or chemotherapy. This can significantly reduce therapy-induced morbidity and improve the patient's quality of life as well as avoiding unnecessary costs. For women with endometrial cancer and a high risk of recurrence, the guideline defines the optimal extent of surgical radicality together with the appropriate chemotherapy and/or adjuvant radiotherapy if required. An evidence-based optimal use of different therapeutic modalities should improve the survival rates and quality of life of these patients. This S3-guideline on endometrial cancer is intended as a basis for certified gynecological cancer centers. The aim is that the quality indicators established in this guideline will be incorporated in the certification processes of these centers. Methods The guideline was compiled in accordance with the requirements for S3-level guidelines. This includes, in the first instance, the adaptation of source guidelines selected using the DELBI instrument for appraising guidelines. Other consulted sources included reviews of evidence, which were compiled from literature selected during systematic searches of literature databases using the PICO scheme. In addition, an external biostatistics institute was commissioned to carry out a systematic search and assessment of the literature for one part of the guideline. Identified materials were used by the interdisciplinary working groups to develop suggestions for Recommendations and Statements, which were then subsequently modified during structured consensus conferences and/or additionally amended online using the DELPHI method, with consent between members achieved online. The guideline report is freely available online. Recommendations Part 2 of this short version of the guideline presents recommendations for the therapy of endometrial cancer including precancers and early endometrial cancer as well as recommendations on palliative medicine, psycho-oncology, rehabilitation, patient information and healthcare facilities to treat endometrial cancer. The management of precancers of early endometrial precancerous conditions including fertility-preserving strategies is presented. The concept used for surgical primary therapy of endometrial cancer is described. Radiotherapy and adjuvant medical therapy to treat endometrial cancer and uterine carcinosarcomas are described. Recommendations are given for the follow-up care of endometrial cancer, recurrence and metastasis. Palliative medicine, psycho-oncology including psychosocial care, and patient information and rehabilitation are presented. Finally, the care algorithm and quality assurance steps for the diagnosis, therapy and follow-up of patients with endometrial cancer are outlined.

Authors with CRIS profile

Involved external institutions

Universitätsklinikum Essen Germany (DE) Martin-Luther-Universität Halle-Wittenberg (MLU) Germany (DE) Universitätsklinikum Göttingen Germany (DE) Universitätsklinikum Heidelberg Germany (DE) HELIOS Kliniken Germany (DE) Westfälische Wilhelms-Universität (WWU) Münster Germany (DE) Universitätsklinikum Freiburg Germany (DE) Universitätsklinikum Köln Germany (DE) Medizinischer Dienst des Spitzenverbandes Bund der Krankenkassen e.V. (MDS) Germany (DE) Sana Klinikum Offenbach Germany (DE) Medizinische Universität Innsbruck Austria (AT) Inselspital, Universitätsspital Bern Switzerland (CH) Winkelwaldklinik Nordrach Germany (DE) Deutsche Rentenversicherung Germany (DE) Klinikum rechts der Isar Germany (DE) Universitätsspital Basel Switzerland (CH) Universitätsklinikum des Saarlandes (UKS) Germany (DE) Deutsche Krebsgesellschaft (DKG) Germany (DE) Steiermärkische Krankenanstaltengesellschaft m. b. H. LKH-Univ. Klinikum Graz Austria (AT) Universitätsmedizin Greifswald / Universitätsklinikum Greifswald Germany (DE) Universitätsklinikum Jena Germany (DE) Rheinische Friedrich-Wilhelms-Universität Bonn Germany (DE) Charité - Universitätsmedizin Berlin Germany (DE) Universitätsklinikum Düsseldorf Germany (DE) Deutscher Verband für Physiotherapie (ZVK) e. V. Germany (DE) Klinikum Harlaching Germany (DE) GPR Gesundheits- und Pflegezentrum Rüsselsheim gemeinnützige GmbH Germany (DE) Ruhr-Universität Bochum (RUB) Germany (DE) Ludwig-Maximilians-Universität (LMU) Germany (DE) St.-Johannes-Hospital Germany (DE) Universität Regensburg Germany (DE) Muldentalkliniken Germany (DE) Universitätsklinikum Leipzig Germany (DE) Universitätsklinikum Magdeburg A.ö.R. Germany (DE) AWMF-Institut für Medizinisches Wissensmanagement (AWMF-IMWi) Germany (DE) Pius-Hospital Oldenburg Germany (DE) Universitätsklinikum Würzburg Germany (DE) Martin-Luther-Krankenhaus Germany (DE) Klinikum Fürth Germany (DE) Frauenselbsthilfe nach Krebs - Bundesverband e. V. Germany (DE) Krankenhaus Jerusalem Germany (DE) Medizinisch Genetisches Zentrum (MGZ) / Medical Genetics Center Germany (DE) Vivantes - Netzwerk für Gesundheit GmbH Germany (DE)

How to cite

APA:

Emons, G., Steiner, E., Vordermark, D., Uleer, C., Bock, N., Paradies, K.,... Erdogan, S. (2018). Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities. Geburtshilfe und Frauenheilkunde, 78(11), 1089-1109. https://dx.doi.org/10.1055/a-0715-2964

MLA:

Emons, Guenter, et al. "Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities." Geburtshilfe und Frauenheilkunde 78.11 (2018): 1089-1109.

BibTeX: Download